tiprankstipranks
Trending News
More News >
Senores Pharmaceuticals Ltd. (IN:SENORES)
:SENORES
India Market

Senores Pharmaceuticals Ltd. (SENORES) Financial Statements

Compare
1 Followers

Senores Pharmaceuticals Ltd. Financial Overview

Senores Pharmaceuticals Ltd.'s market cap is currently ₹34.45B. The company's EPS TTM is ₹6.9; its P/E ratio is 28.18; Senores Pharmaceuticals Ltd. is scheduled to report earnings on January 20, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25
Income Statement
Total Revenue₹ 3.83B
Gross Profit₹ 14.11M
Operating Income₹ 728.10M
EBITDA₹ 1.08B
Net Income₹ 6.85M
Balance Sheet
Cash & Short-Term Investments₹ 3.85B
Total Assets₹ 145.66M
Total Debt₹ 3.15B
Net Debt₹ 24.48M
Total Liabilities₹ 50.70M
Stockholders' Equity₹ 7.86B
Cash Flow
Free Cash Flow₹ -2.03B
Operating Cash Flow₹ -459.20M
Investing Cash Flow₹ -4.29B
Financing Cash Flow₹ 5.73B
Currency in INR

Senores Pharmaceuticals Ltd. Earnings and Revenue History

Senores Pharmaceuticals Ltd. Debt to Assets

Senores Pharmaceuticals Ltd. Cash Flow

Senores Pharmaceuticals Ltd. Forecast EPS vs Actual EPS